Neurocrine Biosciences
NBIX
#1482
Rank
ยฃ9.10 B
Marketcap
ยฃ90.18
Share price
-1.75%
Change (1 day)
-3.01%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Earnings for Neurocrine Biosciences (NBIX)

Earnings in 2024 (TTM): ยฃ0.39 B

According to Neurocrine Biosciences 's latest financial reports the company's current earnings (TTM) are ยฃ0.38 B. In 2023 the company made an earning of ยฃ0.25 B an increase over its 2022 earnings that were of ยฃ0.16 B.The earnings displayed on this page is the company's Pretax Income.

Earnings history for Neurocrine Biosciences from 1996 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) ยฃ0.39 B54.73%
2023 ยฃ0.25 B52.44%
2022 ยฃ0.16 B73.74%
2021 ยฃ96.92 M-8.82%
2020 ยฃ0.10 B77.78%
2019 ยฃ59.78 M49.83%
2018 ยฃ39.9 M-142.57%
2017 -ยฃ93.74 M-14.73%
2016 -ยฃ0.11 B53.15%
2015 -ยฃ71.78 M46.25%
2014 -ยฃ49.08 M29.66%
2013 -ยฃ37.86 M-3530.8%
2012 ยฃ1.1 M-95.73%
2011 ยฃ25.84 M
2009 -ยฃ36.34 M-45.38%
2008 -ยฃ66.52 M-58.87%
2007 -ยฃ0.17 B87.3%
2006 -ยฃ86.35 M351.97%
2005 -ยฃ19.11 M-52.09%
2004 -ยฃ39.88 M-10.98%
2003 -ยฃ44.8 M
2001 -ยฃ33.44 M
1999 -ยฃ15.08 M108.32%
1998 -ยฃ7.24 M
1996 ยฃ2.2 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ยฃ16.34 M-95.70%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.92 B 143.50%๐Ÿ‡ฌ๐Ÿ‡ง UK
-ยฃ25.05 M-106.58%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ6.84 B 1,699.66%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ5.38 B 1,314.61%๐Ÿ‡บ๐Ÿ‡ธ USA
-ยฃ0.93 B-342.64%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ27.05 M-92.89%๐Ÿ‡บ๐Ÿ‡ธ USA
-ยฃ31.83 M-108.36%๐Ÿ‡บ๐Ÿ‡ธ USA